The activity profile of Benolea® has been extensively investigated in various studies. Benolea® develops its activity profile by means of synergy between its multiple constituents. The beneficial effects of Benolea® cannot be attributed to one single substance, but are the result of the synergistic interplay between all extract’s constituents, the multicomponent system.
In addition, Benolea® benefits from an excellent safety profile. The extract did not show any side effects and was well-tolerated in a clinical trial. Toxicological tests further confirm the excellent safety profile of the extract.
Benolea® is an olive leaf extract with clinical evidence. We continue to fund research to further support the clinical efficacy of Benolea®.
- Susalit E, et al., “Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril”. Phytomedicine 18(4): 251-8 (2011).
- Perrinjaquet-Moccetti, et al., “Food Supplementation with an Olive (Olea europaea L.) Leaf Extract Reduces Blood Pressure in Borderline Hypertensive Monozygotic Twins,” Phytother. Res. 22(9), 1239–1242 (2008).
- Khayyal MT, et al., “Blood pressure lowering effect of an olive leaf extract (Olea europaea) in L-NAME induced hypertension in rats”. Arzneimittelforschung 52(11) :797-802 (2002).
Please contact us for study summaries and more information to Benolea®.